Retatrutide 50mg Vial (Triple Receptor Agonist)

Welcome to the official VitalisLabs UK product page for our high-capacity Retatrutide 50mg vial. Formulated for advanced metabolic, endocrine, and cellular energy research, each glass vial contains 50mg of co-lyophilized Retatrutide (LY3437943)—a potent triple agonist designed to simultaneously target the GLP-1, GIP, and Glucagon (GCGR) receptors.

Buy Retatrutide 50mg Vial UK — Analytical Grade Purity

In high-throughput metabolic research and multi-variable trial runs, maintaining consistent compound stability across extended protocols is essential. When you buy retatrutide 50mg vial UK products directly from VitalisLabs, each single vial is freeze-dried under strict vacuum parameters to protect secondary peptide structures and maximize shelf life.

+-----------------------------------------------------------------------+
|                    PRODUCT SPECIFICATION OVERVIEW                     |
|                                                                       |
|  * Product Identifier: VL-RETA-50V                                    |
|  * Unit Format: Single Lyophilized 50mg Glass Vial                    |
|  * Receptor Targets: GLP-1R / GIPR / GCGR (Triple Agonist)             |
|  * Purity Level: >99.0% (HPLC & MS Verified)                          |
|  * CAS Number: 2381089-83-2                                           |
|  * Physical Form: Freeze-Dried / Lyophilized White Powder             |
|                                                                       |
|  [ Download Batch COA Certificate ] ---> Opens PDF                    |
+-----------------------------------------------------------------------+

Triple Receptor Agonism in a Single 50mg Vial

The retatrutide 50mg vial allows laboratories to conduct comparative assays across three distinct metabolic pathways without needing multiple distinct peptide reconstitutions:

1. GIP Receptor (GIPR) Pathway: Stimulates glucose-dependent insulinotropic activity and regulates nutrient-induced lipid signaling.

2. GLP-1 Receptor (GLP-1R) Pathway: Modulates central satiety responses, gastric emptying rates, and postprandial glucose dynamics.

3. Glucagon Receptor (GCGR) Pathway: Enhances hepatic lipid oxidation, increases basal thermogenic energy expenditure, and promotes systemic metabolic flexibility.

Technical Specifications: Retatrutide 50mg Vial

Reconstitution & Laboratory Handling Protocols

1. Storage Prior to Reconstitution: Store unopened 50mg vials in a dark, desiccated freezer at -20°C.

2. Reconstitution Diluent: Reconstitute using sterile bacteriostatic water or laboratory-grade saline solution.

3. Dissolution Method: Direct diluent slowly down the glass wall of the 50mg vial. Allow the lyophilized cake to dissolve completely without mechanical agitation or shaking.

4. Post-Reconstitution Storage: Store reconstituted liquid solutions refrigerated at 2°C to 8°C for active research, or freeze in single-use aliquots at -80°C for long-term stability.

Compliance Disclaimer: All retatrutide 50mg vial products provided by VitalisLabs UK are strictly intended for laboratory in vitro evaluation, analytical reference, and scientific research. They are not intended for human consumption, clinical trials, or therapeutic administration.